Florida Cancer Specialists & Research Institute Welcomes New Cancer Experts in Pinellas County and The Villages

Strategic Insights -

Dr. Troy Fishman and Dr. Yeshanew Teklie, two highly skilled hematologists and medical oncologists, have joined Florida Cancer Specialists & Research Institute, bringing their expertise and dedication to cancer care to Pinellas County and The Villages. Dr. Fishman is now seeing patients at a location in Clearwater, while Dr. Teklie is treating patients at offices in The Villages, Leesburg, and Lady Lake. These additions further strengthen FCS's commitment to delivering world-class cancer care through innovative treatment plans and access to cutting-edge clinical research.

Key Takeaways:

  • Dr. Troy Fishman, MD, has joined Florida Cancer Specialists & Research Institute in Pinellas County, where he is seeing patients at 3280 N. McMullen Booth Rd., Suite 200, Clearwater, FL 33761.
  • Dr. Fishman received his medical degree from St. George's University School of Medicine in Grenada and completed his residency training at the University of Central Florida in Gainesville and a fellowship in oncology/hematology at Roger Williams Medical Center in Providence, Rhode Island.
  • Dr. Fishman's approach emphasizes understanding each patient's unique needs, concerns, and overall well-being, devising personalized treatment plans to achieve the highest quality of life and best possible outcome.
  • Dr. Yeshanew Teklie, MD, has joined the FCS team in The Villages, Leesburg, and Lady Lake, bringing specialized expertise in hematology oncology.
  • Dr. Teklie completed his medical degree at Ross University School of Medicine in the West Indies, followed by residency training at Florida State University at Sarasota Memorial Hospital and a hematology oncology fellowship at the University of Southern California LAC+USC Medical Center in Los Angeles.
  • FCS President & Managing Physician reconoced Dr. Teklie's commitment to service and community care, acknowledging his strong dedication to helping patients achieve the best possible quality of life.
  • Florida Cancer Specialists & Research Institute has a robust clinical research program, providing patients with access to a wide range of clinical trials, making it a leader in research among private oncology practices in Florida and across the country.
  • Before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.
  • FCS's outstanding team of dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

Statistics:

  • Dr. Fishman completed 2 years of fellowship training in oncology/hematology.
  • FCS has over 40 years of experience in delivering world-class cancer care.
  • The majority of new cancer drugs in the U.S. (around 70-80%) were first made available to patients through participation in clinical trials at FCS.
  • FCS's clinical research program has led to significant advancements in oncology care.

Sources:

  • FCS Assistant Managing Physician
  • FCS President & Managing Physician
  • Florida Cancer Specialists & Research Institute, LLC (FLCancer.com)
  • St. George's University School of Medicine
  • University of Central Florida
  • Roger Williams Medical Center
  • Florida State University
  • University of Southern California LAC+USC Medical Center
  • FDA